| JHTGX | LONAX | JHTGX / LONAX | |
| Total Expense Ratio | 0.45 | 2.24 | 20% |
| Annual Report Gross Expense Ratio | 0.46 | 2.24 | 21% |
| Fund Existence | 6 years | 11 years | - |
| Gain YTD | 4.192 | 10.329 | 41% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.23B | 111M | 2,909% |
| Annual Yield % from dividends | 0.66 | 0.00 | - |
| Returns for 1 year | 7.77 | 8.87 | 88% |
| Returns for 3 years | 40.44 | 34.84 | 116% |
| Returns for 5 years | 40.39 | 21.73 | 186% |
| Returns for 10 years | N/A | 132.49 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDEYX | 21.95 | 0.15 | +0.69% |
| Columbia Intrinsic Value Institutional 3 | |||
| DHINX | 14.44 | N/A | N/A |
| Centre Global Infrastructure Investor | |||
| FSPTX | 54.73 | N/A | N/A |
| Fidelity Select Technology | |||
| BCREX | 16.08 | N/A | N/A |
| BlackRock Real Estate Securities Inv C | |||
| FBTDX | 173.92 | N/A | N/A |
| Franklin Biotechnology Discovery C | |||